Send this to a friend

Insulet CEO to retire; COO to succeed

Patrick Sullivan, the CEO of the insulin device company building a $100 million facility in Acton, will retire at the end of the year.
Insulet Corp. president and chief operating officer, Shacey Petrovic, will succeed Sullivan in 2019. She’ll remain in the role as president following the transition.
Timothy Scannell, a board member for the last four years, will become chairman of the Billerica simultaneousl ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media